Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2005
10/05/2005CN1678612A Viral inhibitors
10/05/2005CN1678611A Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist
10/05/2005CN1678610A New quinuclidine amide derivatives
10/05/2005CN1678609A 2-pyrrolidin-2-yl-[1, 3, 4]-oxadiazole derivatives and their use as anti-depressants
10/05/2005CN1678608A New neuropeptide y y5 receptor antagonists
10/05/2005CN1678607A Nitrogen-containing aromatic ring derivatives
10/05/2005CN1678594A Morpholin-acetamide derivatives for the treatment of inflammatory diseases
10/05/2005CN1678592A 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers
10/05/2005CN1678590A Amide derivative and medicine
10/05/2005CN1678586A 取代的喹啉ccr5受体拮抗剂 Substituted quinoline ccr5 receptor antagonist
10/05/2005CN1678585A Therapeutic agents useful for treating pain
10/05/2005CN1678583A Organic acid salt of amlodipine
10/05/2005CN1678581A Indolin phenylsulfonamide derivatives
10/05/2005CN1678579A Indole-3-sulphur derivatives
10/05/2005CN1678578A Indoles having anti-diabetic activity
10/05/2005CN1678577A HMG-COA reductase inhibitors
10/05/2005CN1678576A Pyrrolidine derivatives as oxytocin antagonists
10/05/2005CN1678575A Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative
10/05/2005CN1678573A Diarylurea derivatives and their use as chloride channel blockers
10/05/2005CN1678572A Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
10/05/2005CN1678560A Process for preparing nitrooxyderivatives of naproxen
10/05/2005CN1678372A Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/05/2005CN1678352A Adhesive patch
10/05/2005CN1678351A Adhesive patch
10/05/2005CN1678350A Remedy
10/05/2005CN1678348A Compositions and methods for therapeutic treatment
10/05/2005CN1678340A O-derivatized nocathiacin derivatives
10/05/2005CN1678334A New plant based agents as bioavailability/bioefficacy enhancers for drugs and nutraceuticals
10/05/2005CN1678328A Physiologically balanced, ionized, acidic solution and methodology for use in wound healing
10/05/2005CN1678327A Use of hesperidin or one of its derivatives for making a medicine for bone formation stimulation
10/05/2005CN1678326A 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
10/05/2005CN1678325A Sapogenin derivatives, their synthesis and use and method based upon the use
10/05/2005CN1678324A Estrogen replacement regimen
10/05/2005CN1678323A Use of polyunsaturated ketones for the treatment of psoriasis
10/05/2005CN1678322A New therapeutic uses of (4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl) thieno[2, 3-D]pyrimidine
10/05/2005CN1678321A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
10/05/2005CN1678320A N-biarylmethyl aminocycloalkanecarboxamide derivatives
10/05/2005CN1678319A Ciprofloxacin HCl
10/05/2005CN1678318A Medicament compositions based on tiotropium salts and on salmeterol salts
10/05/2005CN1678317A 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/05/2005CN1678316A Piperidin-2, 6-dione pamoate salts and their use for the treatment of stress-related affective disorders
10/05/2005CN1678314A Glycinamide derivatives as raf-kinase inhibitors
10/05/2005CN1678313A Therapeutic treatment for the metabolic syndrome and type 2 diabetes
10/05/2005CN1678312A Use of CCI-779 as an antineoplastic agent
10/05/2005CN1678311A Aryl carbonyl derivatives as therapeutic agents
10/05/2005CN1678310A Medicament containing disorazoles and derivatives thereof for the treatment of benign and malignant tumoral diseases
10/05/2005CN1678309A Tropical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region
10/05/2005CN1678308A Indometacin preparation for external use
10/05/2005CN1678307A Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors
10/05/2005CN1678305A Carvedilol phosphate salts and/or solvates thereof, correspondinq compositions, and/or methods of treatment
10/05/2005CN1678304A PKC activation as a means for enhancing aAPP-a secretion and improving cognition using bryostatin type compounds
10/05/2005CN1678303A Keto cannabinoids with therapeutic indications
10/05/2005CN1678302A Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
10/05/2005CN1678301A Pasting agent
10/05/2005CN1678300A A pharmaceutical composition useful for treating chronic myeloid leukemia
10/05/2005CN1678299A Composition based on triethyl citrate for the treatment of bacterial infections of the skin
10/05/2005CN1678298A Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder
10/05/2005CN1678297A Method of treating osteoarthritis
10/05/2005CN1678296A Compositions of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumors
10/05/2005CN1678292A Coating suspensions (comprising osmopolymers, osmagents) for forming an expandable osmotic composition in controlled release dosage forms as well as the corresponding method for providing this osmotic
10/05/2005CN1678291A Oral dosage from comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition
10/05/2005CN1678290A Dosage forms for increasing the solubility of slow releas drugs
10/05/2005CN1678277A Methods and compositions for treatment of dermal conditions
10/05/2005CN1678261A Vaginal health products
10/05/2005CN1678203A Novel nutraceutical compositions comprising biotin
10/05/2005CN1678195A Organic acids incorporated edible antimicrobial films
10/05/2005CN1678191A Ant spray containing D-limonene
10/05/2005CN1676607A Cloning genes from streptomyces cyaneogriseus subsp. noncyanogenus for biosynthesis of antibiotics and methods of use
10/05/2005CN1676533A Gecko polysaccharide, and its preparing method and pharmaceutical use
10/05/2005CN1676529A Macrilides ketolide compound, and its preparing method and use
10/05/2005CN1676526A Substituted 2-benzoyl piperazine methyl penem compound, and its preparing method and use
10/05/2005CN1676525A Hydrophilic polymer-thunder good vine extract binding substance and its medicinal composition
10/05/2005CN1676523A Method for preparing antihypertension losartan
10/05/2005CN1676521A Kuh-seng ketone and its derivative and the like and use in preparing anti-tumor medicine
10/05/2005CN1676520A Kuh-seng flavone extract and preparation and use thereof
10/05/2005CN1676513A Novel anti-hypertension chemical entity (TMEP)
10/05/2005CN1676508A Anti-inflammatory and anti-thrombus compound and its medicinal composition
10/05/2005CN1676165A In vivo slow-releasing anticancer medicinal composition
10/05/2005CN1676160A Ginkgo leaf extract and dipyridamole injection formulation and its preparing process
10/05/2005CN1676136A Compound vitamin U atropa belladonna bismuth-aluminium medicine table for treating gastric ulcer
10/05/2005CN1676134A Artificial tear and its preparing method
10/05/2005CN1676133A Doxufylline for injection and its preparing method
10/05/2005CN1676132A Thio-oxy pyrimidine formulation and its preparing method
10/05/2005CN1676131A Composition for treating hyperlipemia
10/05/2005CN1676130A Water-soluble medicine sublingual-medicating formulation
10/05/2005CN1676129A Use of benzy hydrobromide tropine for preparing medicine for treating epilepsia
10/05/2005CN1676128A Carsickness medicine
10/05/2005CN1676127A Dry-wet integrated external-application formulation for treating burn and empyrosis
10/05/2005CN1676126A Method for preparing anticancer, cancer-preventing ocean active medicine
10/05/2005CN1676125A Nano-level emulsion containing taxine or hard-soluble medicine
10/05/2005CN1676124A Antibody chemotherapy-medicine
10/05/2005CN1676121A Slow-release micro-ball formulation for tissue, organ local therapy, and its preparing method and use
10/05/2005CN1676120A Method for preparing hard-soluble gel formulation
10/05/2005CN1221665C Use of negative regulation elements for nerve-specific expression of transgenes
10/05/2005CN1221554C Pyrano [2, 3-C] imidazo[-1, 2-A] pyridine derivatives and mecicine composition for treatment of traitement gastrointestinal disorders
10/05/2005CN1221553C Tricyclic imidazopyridines and medicine composition thereof
10/05/2005CN1221551C Aminotriazolopyridine derivatives as adenosine receptor ligands
10/05/2005CN1221550C Crgstalline form II of cabergoline
10/05/2005CN1221549C Crystalline monohydrate, method for producing the same and the use thereof in the production of medicament
10/05/2005CN1221548C Oxazolidinones having sulfoximine functional group
1 ... 4519 4520 4521 4522 4523 4524 4525 4526 4527 4528 4529 4530 4531 4532 4533 4534 4535 4536 4537 4538 4539 ... 7860